EEG Markers of Neurodevelopmental Disorders: What Can We Learn from Intellectual Disability Syndromes?
November 11th, 2020
This second edition of the TACC Research Forum will feature Dr. Sarah Lippé, Full Professor in the Department of Psychology at the Université de Montréal.
Sarah Lippé Ph.D, neuropsychologist and full professor at the Psychology Department at University of Montreal, studies risk factors for neurodevelopmental disorders and the diversity of trajectories of outcomes. She has developed brain activity biomarkers sensitive to brain maturation and cognitive development. She currently uses advanced imaging signal processing and modern statistics to delineate etiologic mechanisms leading to abnormal neurodevelopment. She was amongst the first to advocate for novel strategies in assessing outcomes in clinical trials and other intervention means aiming at improving cognition in children. Dr. Lippé is currently leading EEG phenotyping of two international Fragile X Syndrome and Autism Spectrum Disorders clinical trials involving multidisciplinary teams of researchers from the POND, the EU-AIMS and the MIND institute, and creating bridges between international teams involved in neurodevelopmental disorders cohorts in order to better understand risks and resilience factors favoring intervention responses. She is also innovatively deeply phenotyping hundreds of children with genetic risks to better understand trajectories to target as early as possible children that would benefit from timely interventions. As a clinical neuropsychologist, she is involved in several community-based initiatives to serve these children.